CoChat
Cited by 201

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia

Open access
Wang, Jinghua, Chen, Siyu, Xiao, Wei, Li, Wende, Wang, Liang, Yang, Shuo, Wang, Weida, Xu, Liping, Liao, Shuangye, Liu, Wenjian, Wang, Yang, Liu, Nawei, Zhang, Jianeng, Xia, Xiaojun, Kang, Tiebang, Chen, Gong, Cai, Xiuyu, Yang, Han, Zhang, Xing, Lu, Yue, Zhou, Penghui · 2018 · Journal of Hematology & Oncology

Abstract

BACKGROUND: Acute myeloid leukemia (AML) is one of the most common types of adult acute leukemia. Standard chemotherapies can induce complete remission in selected patients; however, a majority of patients eventually relapse and succumb to the disease. Thus, the development of novel therapeutics for AML is urgently needed. Human C-type lectin-like molecule-1 (CLL-1) is a type II transmembrane glycoprotein, and its expression is restricted to myeloid cells and the majority of AML blasts. Moreover, CLL-1 is expressed in leukemia stem cells (LSCs), but absent in hematopoietic stem cells (HSCs), which may provide a potential therapeutic target for AML treatment. METHODS: We tested the expression of CLL-1 antigen on peripheral blood cells and bone marrow cells in healthy donor and AML patients. Then, we developed a chimeric antigen receptor (CAR) containing a CLL1-specific single-chain variable fragment, in combination with CD28, 4-1BB costimulatory domains, and CD3-ζ signaling domain. We further investigate the function of CLL-1 CAR-T cells. RESULTS: myeloid progenitor cells and mature myeloid cells were specifically eliminated by CLL-1 CAR-T cells, while normal HSCs were not targeted due to the lack of CLL-1 expression. CONCLUSIONS: CLL-1 CAR-T represents a promising immunotherapy for the treatment of AML.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13045-017-0553-5

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 201

Metadata

Authors
Wang, J., Chen, S., Xiao, W., Li, W., Wang, L., Yang, S., Wang, W., Xu, L., Liao, S., Liu, W., Wang, Y., Liu, N., Zhang, J., Xia, X., Kang, T., Chen, G., Cai, X., Yang, H., Zhang, X., Lu, Y., & Zhou, P.
Venue
Journal of Hematology & Oncology
Published
2018-01-10
Volume
11
Issue
1
Pages
7-7
ISSN
1756-8722 (ISSN-L)
OpenAlex
W2783779434
Cited by
201
References
5
FWCI
6.57
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia. https://app.cochat.ai/papers/10.1186/s13045-017-0553-5
The paper
Wang, J., Chen, S., Xiao, W., Li, W., Wang, L., Yang, S., Wang, W., Xu, L., Liao, S., Liu, W., Wang, Y., Liu, N., Zhang, J., Xia, X., Kang, T., Chen, G., Cai, X., Yang, H., Zhang, X., . . . Zhou, P. (2018). CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia. Journal of Hematology & Oncology. https://doi.org/10.1186/s13045-017-0553-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.